RT Book, Section
A1 Lipworth, Adam D.
A1 Saavedra, Arturo P.
A1 Weinberg, Arnold N.
A1 Johnson, Richard Allen
A2 Goldsmith, Lowell A.
A2 Katz, Stephen I.
A2 Gilchrest, Barbara A.
A2 Paller, Amy S.
A2 Leffell, David J.
A2 Wolff, Klaus
SR Print(0)
ID 56082056
T1 Chapter 178. Non-Necrotizing Infections of the Dermis and Subcutaneous Fat: Cellulitis and Erysipelas
T2 Fitzpatrick's Dermatology in General Medicine, 8e
YR 2012
FD 2012
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-166904-7
LK accessmedicine.mhmedical.com/content.aspx?aid=56082056
RD 2024/04/16
AB |PrintNon-Necrotizing  Infections  of  the  Dermis  and  Subcutaneous  Tissue  at  a  GlanceApproximately  7%–10%  of  hospitalizations  in  North  America  are  due  to  skin  and  soft-tissue  infections  (SSTI),  including  cellulitis  and  erysipelas.The  incidence  of  SSTI  is  increasing,  paralleling  the  rise  of  methicillin-resistant  Staphylococcus  aureus.A  high  index  of  suspicion  for  resistant  organisms  shoamaintained  for  cases  that  do  not  improve  rapidly  with  empiric  therapy,  or  in  areas  where  resistant  strains  have  been  reported.Newer  antibiotics  are  currently  available  or  undergoing  testing  to  treat  resistant  infections  caused  by  methicillin-resistant  or  vancomycin-resistant  strains.Microbiologic  data  from  various  culture  techniques  is  helpful,  but  swabs,  aspirations,  and  tissue  cultures  generally  have  a  low  yield  for  uncomplicated  cellulitis  and  erysipelas.Non-necrotizing  soft-tissue  infections  are  treated  with  antibiotics  and  supportive  measures,  with  drainage  of  collections  as  needed.